102 related articles for article (PubMed ID: 21521279)
1. Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP).
Spilcke-Liss E; Friedrich N; Dörr M; Schminke U; Völzke H; Brabant G; Nauck M; Wallaschofski H
Clin Endocrinol (Oxf); 2011 Jul; 75(1):70-5. PubMed ID: 21521279
[TBL] [Abstract][Full Text] [Related]
2. Correlation of serum IGF-I and IGFBP-1 and -3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men.
Boquist S; Ruotolo G; Skoglund-Andersson C; Tang R; Björkegren J; Bond MG; de Faire U; Brismar K; Hamsten A
Clin Endocrinol (Oxf); 2008 Jan; 68(1):51-8. PubMed ID: 17803702
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
[TBL] [Abstract][Full Text] [Related]
4. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.
Kawachi S; Takeda N; Sasaki A; Kokubo Y; Takami K; Sarui H; Hayashi M; Yamakita N; Yasuda K
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284
[TBL] [Abstract][Full Text] [Related]
5. Relation of IGF-I with subclinical cardiovascular markers including intima-media thickness, left ventricular mass index and NT-proBNP.
Eichner M; Wallaschofski H; Schminke U; Völzke H; Dörr M; Felix SB; Nauck M; Friedrich N
Eur J Endocrinol; 2020 Jan; 182(1):79-90. PubMed ID: 31705797
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3) and leptin levels are related to abdominal aortic intima-media thickness in macrosomic newborns.
Koklu E; Kurtoglu S; Akcakus M; Yikilmaz A; Gunes T
Growth Horm IGF Res; 2007 Feb; 17(1):26-32. PubMed ID: 17113804
[TBL] [Abstract][Full Text] [Related]
7. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
[TBL] [Abstract][Full Text] [Related]
8. Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population.
Martin RM; Gunnell D; Whitley E; Nicolaides A; Griffin M; Georgiou N; Davey Smith G; Ebrahim S; Holly JM
J Clin Endocrinol Metab; 2008 Apr; 93(4):1331-8. PubMed ID: 18211967
[TBL] [Abstract][Full Text] [Related]
9. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
[TBL] [Abstract][Full Text] [Related]
10. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
[TBL] [Abstract][Full Text] [Related]
11. Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.
Harb AN; Holtfreter B; Friedrich N; Wallaschofski H; Nauck M; Albers M; Meisel P; Biffar R; Kocher T
J Clin Periodontol; 2012 Oct; 39(10):931-9. PubMed ID: 22882716
[TBL] [Abstract][Full Text] [Related]
12. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.
Colao A; Spiezia S; Di Somma C; Pivonello R; Marzullo P; Rota F; Musella T; Auriemma RS; De Martino MC; Lombardi G
J Endocrinol Invest; 2005 May; 28(5):440-8. PubMed ID: 16075928
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and atrial fibrillation in the elderly.
Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Seux ML; Treluyer JM; Epelbaum J; Bouc YL; Hanon O
J Gerontol A Biol Sci Med Sci; 2014 Aug; 69(8):1025-32. PubMed ID: 24368776
[TBL] [Abstract][Full Text] [Related]
14. Relation of insulin-like growth factor-I and IGF binding protein 3 with markers of inflammation: results of a population-based study.
Lohr J; Grotevendt A; Nauck M; Völzke H; Wallaschofski H; Friedrich N
Clin Endocrinol (Oxf); 2014 Jan; 80(1):148-54. PubMed ID: 23662939
[TBL] [Abstract][Full Text] [Related]
15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
[TBL] [Abstract][Full Text] [Related]
16. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
17. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population.
Hannemann A; Wallaschofski H; Rettig R; Völzke H; Samietz S; Nauck M; Bidlingmaier M; Friedrich N
Horm Metab Res; 2012 Mar; 44(3):228-33. PubMed ID: 22328165
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating IGF-I and IGFBP-3 concentrations and exercise capacity in healthy volunteers: results of the Study of Health in Pomerania.
Gläser S; Friedrich N; Ewert R; Schäper C; Krebs A; Dörr M; Völzke H; Felix SB; Nauck M; Wallaschofski H; Koch B
Growth Horm IGF Res; 2010 Dec; 20(6):404-10. PubMed ID: 20889360
[TBL] [Abstract][Full Text] [Related]
20. The association between IGF-I/IGFBP-3 and subclinical end points: epidemiology faces the limits.
Müller C; Wallaschofski H; Brabant G; Wahnschaffe U; Samietz S; Nauck M; Friedrich N
J Clin Endocrinol Metab; 2014 Aug; 99(8):2804-12. PubMed ID: 24823454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
